Bruker Corporation. (9/5/17). "Press Release: Bruker Corporation to Present at the 15th Annual Morgan Stanley Global Healthcare Conference". Billerica, MA.

	Region	New York, NY
	Country	United States (USA)
	Organisation	Bruker Corporation (Nasdaq: BRKR)
	Group	Bruker (Group)
	Organisation 2	Morgan Stanley & Co. Inc.
	Group	Morgan Stanley (Group)
	Product	Morgan Stanley Global Healthcare Conference 2017 New York
	Product 2	analytical instrument
	Index term	Bruker–Morgan Stanley: investor conference, 201709 supply service Bruker presents at Morgan Stanley Global Healthcare Conference NY
	Person	Srega, Jürgen (Bruker 201302– President Bruker CALID Group before BRAHMS + Thermo Fisher Bremen)
	Person 2	Minkova, Miroslava (Vertex 202303 Investor Relations formerly Bruker Corp 201611 Head of Investor Relations)

Bruker Corporation (NASDAQ: BRKR) announced today it will present at the 15th Annual Morgan Stanley Global Healthcare Conference. Juergen Srega, President of the Bruker CALID Group, will participate in a "fireside chat" Q&A session on behalf of the company on Monday, September 11th, 2017 at 1:40 PM Eastern Time.

A live audio webcast of the presentation will be available on the Investor section of the Company's website at http://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation website after the event and will be available for 30 days following the presentation.

About Bruker Corporation

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nanoanalysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.

Contact:
Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com

Record changed: 2023-06-05